DR10.8-9 | Urethral Discharge Diagnosis and Syndromic Management — Summary & Reflection

KEY TAKEAWAYS

Urethral discharge is a common STI syndrome caused by gonococcal urethritis (Neisseria gonorrhoeae — Gram-negative intracellular diplococci on smear, copious purulent discharge) and non-gonococcal urethritis (chiefly Chlamydia trachomatis serovars D-K, also Mycoplasma genitalium and Ureaplasma — mucoid or scanty discharge). Because the two frequently coexist and cannot be reliably separated clinically, NACO syndromic management with Kit 1 (grey) — per current NACO guidance — treats both organisms together at first contact: a cephalosporin (cefixime or ceftriaxone) for gonorrhoea plus azithromycin or doxycycline for chlamydia, with ceftriaxone-based regimens favoured because of rising gonococcal cephalosporin resistance. A urethral smear, where available, distinguishes gonococcal (PMNs with intracellular diplococci) from non-gonococcal urethritis but does not change the both-organism principle. Complete management with partner treatment regardless of symptoms, condom promotion, counselling to complete the course and abstain during treatment, an HIV-testing offer, and follow-up — reassessing persistent symptoms for reinfection, resistance, or Mycoplasma genitalium.

REFLECT

Consider a patient who is reluctant to inform his partner about his diagnosis, fearing the relationship will end. Reflect on how you would counsel him so that the partner is treated — protecting both the partner's health and your patient from reinfection — while respecting confidentiality and autonomy. How will you explain, in language a non-medical person understands, why a single tablet is not enough and why the partner must be treated even without symptoms? What concrete words will you use to make the case for completing the full course and returning for follow-up?